Modification of the L1-CAM carboxy-terminus in pancreatic adenocarcinoma cells

Tumor Biology

Volumn 32, Issue 2, 2011, Pages 347-357

  Chen, Maxine M ^a   Lee, Chia Yao ^a   Leland, Hyuma A ^a   Silletti, Steve ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Conformation; Deamidation; Differentiation; L1 CAM

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE L1; PROTEIN RANBPM; REGULATOR PROTEIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG; ANTIBODY; CD20 ANTIGEN; EPITOPE; TUMOR MARKER;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITOPE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; ADENOCARCINOMA; CELL DIFFERENTIATION; IMMUNOLOGY; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIBODIES; ANTIGENS, CD20; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITOPES; HUMANS; NEURAL CELL ADHESION MOLECULE L1; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953767777     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0127-4     Document Type: Article

References (37)

1. NCI-Pancreatic Cancer Progress Review Group. National Cancer Institute Strategic plan for addressing the recommendations of the Pancreatic Cancer Progress Review Group. PANC-PRG Implementation Plan. Bethesda: National Cancer Institute; 2002.
2. National Cancer Institute PDQ Database. Available online at http://www.cancer.gov/cancertopics/pdq
3. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev. 2002;2:897-909. (Pubitemid 37328891)
4. Aguire AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003;17:3112-26. (Pubitemid 38040774)
5. Hingorani SR, Petricoin III EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437-50. (Pubitemid 38050041)
6. Burden-Gulley SM, Pendergast M, Lemmon V. The role of cell adhesion molecule L1 in axonal extension, growth cone motility, and signal transduction. Cell Tissue Res. 1997;290:415-22. (Pubitemid 27470076)
7. Silletti S, Altevogt P, Montgomery AMP. L1 cell adhesion molecule (CD171). CD171 guide for the International Workshop in Human Leukocyte Differentiation Antigens and the online "Protein Reviews on the Web" (PROW) (www.ncbi.nlm.nih.gov/prow). Prow. 2000;1:31-7.
8. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet. 2003;362:869-75. (Pubitemid 37130096)
9. Fogel M, Mechtersheimer S, Huszar M, Smirnov A, Abu-Dahi A, Tilgen W, et al. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Letts. 2003;189:237-47. (Pubitemid 35462000)
10. Daponte A, Kostopoulou E, Kollia P, Papamichali R, Vanakara P, Hadjichristodoulou C, et al. L1-CAM in ovarian serous neoplasms. Eur J Gvnaecol Oncol. 2008;29:26-30.
11. Kaifi JT, Heidtmann S, Schurr PG, Reichelt U, Mann O, Yekebas EF, et al. Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine tumors. Anticancer Res. 2006;26:1167-70.
12. Muerkoster SS, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene. 2007;26:2759-68. (Pubitemid 46663831)
13. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AMP. The cell adhesion molecule L1 promotes a motile and invasive phenotype via sustained MAP-kinase activation, gene transcription and induction of integrin-dependent migration. J Biol Chem. 2004;279:28880-8.
14. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, et al. L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005;168:633-42. (Pubitemid 40271028)
15. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 2007;67:7703-12. (Pubitemid 47281363)
16. Cheng L, Lemmon S, Lemmon V. RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation. J Neurochem. 2005;94:1102-10. (Pubitemid 41170596)
17. Gast D, Riedle S, Issa Y, Pfiefer M, Beckhove P, Sanderson MP, et al. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene. 2008;27:1281-9. (Pubitemid 351294696)
18. Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G, Lemmon V. Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem. 1999;274:37965-73. (Pubitemid 30026865)
19. Chen MM, Lee C-Y, Leland HA, Lin GY, Montgomery AM, Silletti S. Inside-out regulation of L1 conformation, integrin binding, proteolysis, and concomitant cell migration. Mol Biol Cell. 2010;21:1671-85.
20. Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter D, et al. Factors influencing survival after resection for periampullary neoplasms. Am J Surg. 2000;180:13-7.
21. Kajiji SM (1984) Intraneoplastic diversity in human pancreatic cancer. Dissertation, Brown University
22. Beer S, Oleszewski M, Gutwein P, Geiger C, Altevogt P. Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. J Cell Sci. 1999;112:2667-75. (Pubitemid 29429790)
23. Nayeem N, Silletti S, Yang X, Lemmon VP, Reisfeld RA, Stallcup WB, et al. A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1. J Cell Sci. 1999;112:4739-49. (Pubitemid 30034821)
24. Wong EV, Schaefer AW, Landreth G, Lemmon V. Involvement of p90rsk in neurite outgrowth mediated by the cell adhesion molecule L1. J Biol Chem. 1996;271:18217-23. (Pubitemid 26250815)
25. Herron LR, Hill M, Davey F, Gunn-Moore FJ. The intracellular interactions of the L1 family of cell adhesion molecules. Biochem J. 2009;419:519-31.
26. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635-48. (Pubitemid 44647421)
27. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull. 2005;28:1590-6. (Pubitemid 41324114)
28. Dahlin-Huppe K, Berglund EO, Ranscht B, Stallcup WB. Mutational analysis of the L1 neuronal cell adhesion molecule identifies membrane-proximal amino acids of the cytoplasmic domain that are required for cytoskeletal anchorage. Mol Cell Neurosci. 1997;9:144-56. (Pubitemid 27342645)
29. Chen MM, Leland HA, Lee C-Y, Silletti S. Tyrosine and serine phosphorylation regulate the conformation and subsequent threonine phosphorylation of the L1 cytoplasmic domain. Biochem Biophys Res Commun. 2009;389:257-64.
30. Junghans RP, Stone AL, Lewis MS. Biophysical characterization of a recombinant soluble interleukin 2 receptor (Tac). Evidence for a monomeric structure. J Biol Chem. 1996;271:10453-60. (Pubitemid 26149889)
31. Meredith Jr JE, Kiosses WB, Takada Y, Schwartz MA. Mutational analysis of cell cycle inhibition by integrin β1c. J Biol Chem. 1999;274:8111-6.
32. Primiano T, Baig M, Maliyekkel A, Chang B-D, Fellars S, Sadhu J, et al. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell. 2003;4:41-53. (Pubitemid 36904160)
33. Surette MG, Stock JB. Role of α-helical coiled-coil interactions in receptor dimerization, signaling, and adaptation during bacterial chemotaxis. J Biol Chem. 1996;271:17966-73. (Pubitemid 26250780)
34. Severs JC, Froland WA. Dimerization of a PACAP peptide analogue in DMSO via asparagines and aspartic acid residues. J Pharm Sci. 2007;97:1246-56.
35. Curnis F, Longhi R, Crippa L, Cattaneo A, Dondossola E, Bachi A, et al. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem. 2006;281:36466-76. (Pubitemid 46041380)
36. Gupta R, Srivastava OP. Effect of deamidation of asparagine 146 on functional and structural properties of human lens αB-crystallin. J Biol Chem. 2004;279:44258-69. (Pubitemid 39430829)
37. Ramachandran GN. Stereochemistry of collagen. Int J Pept Protein Res. 1988;31:1-16.